Exact Mass: 1092.6430298

Exact Mass Matches: 1092.6430298

Found 35 metabolites which its exact mass value is equals to given mass value 1092.6430298, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Notoginsenoside I

2-{[2-(5-{[4,5-dihydroxy-6-(hydroxymethyl)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-2,6,6,10,11-pentamethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl)-6-methylhept-5-en-2-yl]oxy}-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol

C54H92O22 (1092.6079932)

Notoginsenoside I is found in tea. Notoginsenoside I is a constituent of Panax notoginseng (sanchi) Constituent of Panax notoginseng (sanchi). Notoginsenoside I is found in tea.

Caspofungin

N-[(3S,6S,9S,11R,15S,20R,21S,24S,25S)-3-[(1R)-3-Amino-1-hydroxypropyl]-21-[(2-aminoethyl)amino]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-5,8,11,17,20,23,25-heptahydroxy-15-[(1R)-1-hydroxyethyl]-2,14-dioxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0⁹,¹³]heptacosa-4,7,16,22-tetraen-18-yl]-10,12-dimethyltetradecanimidate

C52H88N10O15 (1092.6430298)

Caspofungin (brand name Cancidas worldwide) is an antifungal drug, the first of a new class termed the echinocandins from Merck & Co., Inc. It shows activity against infections with Aspergillus and Candida, and works by inhibiting (1,3)-D-Glucan of the fungal cell wall. Caspofungin is administered intravenously. J - Antiinfectives for systemic use > J02 - Antimycotics for systemic use > J02A - Antimycotics for systemic use D000890 - Anti-Infective Agents > D000935 - Antifungal Agents > D054714 - Echinocandins D004791 - Enzyme Inhibitors

Longestin

C61H88O17 (1092.6021198)

3beta,19,20(S)-trihydroxydammar-24-ene-3-O-[beta-D-glucopyranosyl(2->1)-beta-D-glucopyranosyl]-20-O-[alpha-L-rhamnopyranosyl(6->1)-beta-D-glucopyranoside]

C54H92O22 (1092.6079932)

(3beta,12beta,20S)-3-{[2-O-(beta-D-glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-20-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside|gynosaponin V

C54H92O22 (1092.6079932)

C54H92O22

C54H92O22 (1092.6079932)

Gynosaponin E|Gypenoside V

C54H92O22 (1092.6079932)

3??,20S,21-Trihydroxydammar-24-ene 3-O-{[??-L-rhamnopyranosyl(1鈥樏傗垎2)][??-D-glucopyranosyl(1鈥樏傗垎3)]-??-D-glucopyranosyl}-21-O-??-D-glucopyranoside

C54H92O22 (1092.6079932)

Capsofungin

N-[(3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-3-[(1R)-3-amino-1-hydroxypropyl]-21-[(2-aminoethyl)amino]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0^{9,13}]heptacosan-18-yl]-10,12-dimethyltetradecanamide

C52H88N10O15 (1092.6430298)

Notoginsenoside I

2-{[4,5-dihydroxy-6-(hydroxymethyl)-2-{[2,6,6,10,11-pentamethyl-14-(6-methyl-2-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}hept-5-en-2-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-5-yl]oxy}oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C54H92O22 (1092.6079932)

Cancidas

(4R,5S)-5-((2-aminoethyl)amino)-N(2)-(10,12-dimethyltetradecanoyl)-4-hydroxy-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(p-hydroxyphenyl)-L-threonyl-threo-3-hydroxy-L-ornithyl-trans-3-hydroxy-L-proline cyclic (6-1)-peptide

C52H88N10O15 (1092.6430298)

J - Antiinfectives for systemic use > J02 - Antimycotics for systemic use > J02A - Antimycotics for systemic use D000890 - Anti-Infective Agents > D000935 - Antifungal Agents > D054714 - Echinocandins C254 - Anti-Infective Agent > C514 - Antifungal Agent D004791 - Enzyme Inhibitors

Caspofungin

C52H88N10O15 (1092.6430298)

(4R,5S)-5-((2-aminoethyl)amino)-N(2)-(10,12-dimethyltetradecanoyl)-4-hydroxy-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(p-hydroxyphenyl)-L-threonyl-threo-3-hydroxy-L-ornithyl-trans-3-hydroxy-L-proline cyclic (6-1)-peptide

C52H88N10O15 (1092.6430298)

5-acetamido-2-[2-[6-[(E)-2-[[(4Z,7Z)-hexadeca-4,7-dienoyl]amino]-3-hydroxytetradec-4-enoxy]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-6-(1,2,3-trihydroxypropyl)oxane-2-carboxylic acid

5-acetamido-2-[2-[6-[(E)-2-[[(4Z,7Z)-hexadeca-4,7-dienoyl]amino]-3-hydroxytetradec-4-enoxy]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-6-(1,2,3-trihydroxypropyl)oxane-2-carboxylic acid

C53H92N2O21 (1092.6192262)

Adgga 22:6_16:4_20:5

C67H96O12 (1092.6901416)

Adgga 18:5_20:5_20:5

C67H96O12 (1092.6901416)

Adgga 18:5_18:4_22:6

C67H96O12 (1092.6901416)

Adgga 16:4_20:5_22:6

C67H96O12 (1092.6901416)

Adgga 22:5_18:5_18:5

C67H96O12 (1092.6901416)

Adgga 18:4_18:5_22:6

C67H96O12 (1092.6901416)

Adgga 20:5_18:5_20:5

C67H96O12 (1092.6901416)

Adgga 20:5_16:4_22:6

C67H96O12 (1092.6901416)

Adgga 18:5_18:5_22:5

C67H96O12 (1092.6901416)

Adgga 22:6_18:4_18:5

C67H96O12 (1092.6901416)

MLCL 47:4

C56H102O16P2 (1092.6642752)

GM3 30:3;O2

C53H92N2O21 (1092.6192262)

2-{[2-(7-{[4,5-dihydroxy-6-(hydroxymethyl)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl)-6-methylhept-5-en-2-yl]oxy}-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol

2-{[2-(7-{[4,5-dihydroxy-6-(hydroxymethyl)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl)-6-methylhept-5-en-2-yl]oxy}-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol

C54H92O22 (1092.6079932)

(2s,3r,4s,5s,6r)-2-{[(2s)-2-[(1s,3ar,3br,5ar,7s,9ar,9br,11ar)-7-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-en-2-yl]oxy}-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(2s)-2-[(1s,3ar,3br,5ar,7s,9ar,9br,11ar)-7-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-en-2-yl]oxy}-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol

C54H92O22 (1092.6079932)

11-[(6-carboxy-4,5-dihydroxy-3-methoxyoxan-2-yl)oxy]-32-hydroxy-22,26-bis(hydroxymethyl)-32-(3-methoxy-3-oxopropyl)-2,6,10,13,14,17,18,39-octamethyl-34-oxo-27,33-dioxadecacyclo[20.19.0.0²,¹⁹.0⁵,¹⁸.0⁶,¹⁵.0⁹,¹⁴.0²³,³⁹.0²⁶,³⁸.0²⁸,³⁶.0³¹,³⁵]hentetraconta-28(36),29,31(35)-triene-10-carboxylic acid

11-[(6-carboxy-4,5-dihydroxy-3-methoxyoxan-2-yl)oxy]-32-hydroxy-22,26-bis(hydroxymethyl)-32-(3-methoxy-3-oxopropyl)-2,6,10,13,14,17,18,39-octamethyl-34-oxo-27,33-dioxadecacyclo[20.19.0.0²,¹⁹.0⁵,¹⁸.0⁶,¹⁵.0⁹,¹⁴.0²³,³⁹.0²⁶,³⁸.0²⁸,³⁶.0³¹,³⁵]hentetraconta-28(36),29,31(35)-triene-10-carboxylic acid

C61H88O17 (1092.6021198)

(2s,3r,4s,5s,6r)-2-{[(2s)-2-[(1s,3as,3bs,5ar,7s,9as,9bs,11as)-7-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-9a-(hydroxymethyl)-3b,6,6,11a-tetramethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-en-2-yl]oxy}-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(2s)-2-[(1s,3as,3bs,5ar,7s,9as,9bs,11as)-7-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-9a-(hydroxymethyl)-3b,6,6,11a-tetramethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-en-2-yl]oxy}-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxane-3,4,5-triol

C54H92O22 (1092.6079932)